Start your own journey to clinic

Please provide us with a few details so that we can match you with the right expert in your field.

*Required

Thank you, your request has been received.

We're busy connecting you with an expert, who will be in touch as soon as possible.

Oops! Something went wrong while submitting the form. Please try again or email us at webenquiries@conceptlifesciences.com

Hit Generation

Hit generation is where we aim to identify promising compounds that have the potential to become therapeutic drugs. The term "hit" refers to a chemical compound or biologic that exhibits a specific activity of interest, such as inhibiting a disease-related protein or modulating a biological pathway. For small molecules, this phase involves screening medium (1,000 – 10,000) to large (10,000 – 1,000,000) libraries of compounds, which may include natural products, synthetic chemicals including small fragments, or molecules generated through computational approaches for their biological activity. Once hits are identified, they then undergo further optimisation in the lead generation and lead optimisation phases to enhance their drug-like properties, such as efficacy, selectivity, and safety. The ultimate goal of hit generation is to provide a starting point for the development of a drug candidate that can progress through preclinical and clinical testing. The success of hit generation is crucial for the overall success of the drug discovery process, as it lays the foundation for the subsequent stages of drug discover and development.

Connected servicesMore informationSpeak to an expert